SCHEMBL18753365

SCHEMBL18753365

O=C(c1ccc(N[SH](=O)=O)c(C(F)(F)F)c1)N1CCN(C(=O)c2cnccn2)CC1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 2/20 0.45
▸ USP2 O75604 4/20 0.43
▸ CYP3A4 P08684 4/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ CYP2D6 P10635 3/20 0.42
▸ LMNA P02545 1/20 0.40
▸ NAMPT P43490 2/20 0.40
▸ CYP1A2 P05177 3/20 0.39
▸ GAA P10253 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ LRRK2 Q5S007 1/20 0.39
▸ DPP4 P27487 1/20 0.39
▸ DPP9 Q86TI2 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ EGFR P00533 1/20 0.38
▸ BRAF P15056 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18753490 0.86 DPP4 (0.45) P2RX7USP2CYP3A4MEN1KMT2A
SCHEMBL18753793 0.86 CYP2D6 (0.47) USP2CYP3A4MEN1KMT2ACYP2D6
SCHEMBL18753362 0.85 PKM (0.52) MEN1KMT2ACYP2C9
SCHEMBL18753306 0.84 GBA1 (0.44) USP2CYP3A4CYP2D6LMNANAMPT
SCHEMBL18753861 0.84 MGLL (0.45) CYP2D6NAMPTCYP2C9LRRK2
SCHEMBL19562111 0.82 CYP2D6 (0.43) USP2CYP3A4MEN1KMT2ACYP2D6
SCHEMBL20750396 0.79 CYP3A4 (0.51) USP2CYP3A4MEN1KMT2ACYP2D6
SCHEMBL18753391 0.77 ALDH1A1 (0.48) MEN1KMT2ALMNACYP1A2CYP2C9
SCHEMBL2703534 0.76 PKM (0.58) —
SCHEMBL18753748 0.76 RBP4 (0.47) P2RX7LMNANAMPTLRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448582-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2017-04-19 — — EP disclosed
Send feedback